Investor profile

Gil Sambrano

Government-backed & Vice President of Portfolio Development and Review at California Institute for Regenerative Medicine

San Francisco·California·United States

Gil Sambrano is a Vice President of Portfolio Development and Review at California Institute for Regenerative Medicine, whose known portfolio counts 20 companies.

Is Gil Sambrano a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Stage: Pre-Seed Seed
Sector: Education Healthcare
Focus: Biotech Diagnostics Drug Discovery Genomics MedTech PharmaStem Cell Research

Contacts

Available after registration.

Get contact

Affiliated funds' portfolios

Vice President of Portfolio Development and Review at California Institute for Regenerative Medicine, whose known portfolio counts 20 companies

Neurona Therapeutics
Ray Therapeutics
Senti Biosciences
Tenaya Therapeutics
Entos Pharmaceuticals
Eureka Therapeutics
Immusoft
Kenai Therapeutics
Ossium Health
Stanford University
TR1X
Cure Rare Disease
and 8 more

Investor Profile

Founders in the listed sectors Education and Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and Genomics fall inside that listing.

Stage-wise, the deals at California Institute for Regenerative Medicine cluster around Pre-Seed and Seed rounds.

What the affiliated firm has backed is the closest available signal on whether Gil Sambrano is worth approaching.

Frequently asked questions

Who is Gil Sambrano?

Gil Sambrano is a government-backed investor based in San Francisco, California, United States, listed as Vice President of Portfolio Development and Review at California Institute for Regenerative Medicine. The known portfolio of that firm counts 20 companies. That portfolio belongs to the firm, not to Gil Sambrano personally.

What does Gil Sambrano invest in?

Listed sectors include Education and Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does Gil Sambrano invest at?

California Institute for Regenerative Medicine appears in Pre-Seed and Seed rounds across its known deals, and Gil Sambrano is listed there as Vice President of Portfolio Development and Review. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

Which firm is Gil Sambrano listed at?

Gil Sambrano is listed as Vice President of Portfolio Development and Review at California Institute for Regenerative Medicine, whose known portfolio counts 20 companies.

How do I contact Gil Sambrano?

A LinkedIn page is on file for Gil Sambrano. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal